Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders
View Patent ↗The present disclosure relates to methods, devices, and systems used for the treatment of mood, anxiety, cognitive, and behavioral disorders (collectively, neuropsychiatric disorders) via stimulation of the superficial elements of the trigeminal nerve (“TNS”). More specifically, minimally invasive systems, devices and methods of stimulation of the superficial branches of the trigeminal nerve located extracranially in the face, namely the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, nasal and mentalis nerves (also referred to collectively as the superficial trigeminal nerve) are disclosed herein.
1. A method for treating a neuropsychiatric disorder by trigeminal nerve stimulation, comprising:
implanting a subcutaneous electrode assembly in a patient so that a first electrode contact is in contact with a supraorbital nerve on one side of a patient's forehead and so that a second electrode contact is in contact with a supraorbital nerve on an opposing side of the patient's forehead; and
applying electrical signals to the electrode assembly so that current flows between the first electrode contact and the second electrode contact at specified operational parameters to treat the neuropsychiatric disorder, wherein the electrical signals are applied to minimize current penetration into a brain for the patient such that a charge density at the brain's surface does not exceed 20 μC/cm 2 .
2. The method of claim 1 , wherein the step of applying electrical signals comprises applying electrical signals at a frequency between approximately 20 and 300 Hertz, at a current of 0.1 to 3 milliamperes (mA) and at a pulse duration of less than or equal to 500 microseconds.
3. The method of claim 1 , wherein the step of applying electrical signals comprises applying electrical signals at a frequency between approximately 20 and 300 Hertz, at a pulse duration between approximately 50 and 500 microseconds, at an output current density of not greater than approximately 25 mA/cm 2 and a charge density of not greater than approximately 10 microCoulomb/cm 2 at the cerebral cortex.
4. The method of claim 1 , wherein the neuropsychiatric disorder is selected from the group consisting of: mood disorder, cognitive disorder, behavioral disorder and anxiety disorder.